Diseases & Disorders
(G198)
990 on File
MOLLIE BIGGANE MELANOMA FOUNDATION INC
Financial strength (30%)
89/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$183K
Total Revenue
$254K
Total Expenses
$119K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
81.4%
Fundraising Efficiency
N/A
Operating Reserve
5.63x
Liability-to-Asset
10.6%
Revenue Diversification
98.8%
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
81.4% | 83.1% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.6% | 10.9% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.0% | 0.3% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.6 mo | 12.0 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
10.6% | 0.7% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.8% | 93.9% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-2.1% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-7.7% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-39.2% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $183K | $254K | $119K | 81.4% | 0 |
| 2023 | $186K | $275K | $190K | 83.5% | 0 |
| 2022 | $141K | $172K | $278K | 77.0% | 0 |
| 2021 | $438K | $160K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.